BEVACIZUMAB-BVZR: 580 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
580
Total FAERS Reports
190 (32.8%)
Deaths Reported
124
Hospitalizations
580
As Primary/Secondary Suspect
21
Life-Threatening
6
Disabilities
Prescription
Status
FDA Application: 761099 ·
First Report: 20180601 · Latest Report: 20250514
What Are the Most Common BEVACIZUMAB-BVZR Side Effects?
#1 Most Reported
Off label use
159 reports (27.4%)
#2 Most Reported
Death
149 reports (25.7%)
#3 Most Reported
Neoplasm progression
80 reports (13.8%)
All BEVACIZUMAB-BVZR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 159 | 27.4% | 48 | 40 |
| Death | 149 | 25.7% | 149 | 13 |
| Neoplasm progression | 80 | 13.8% | 28 | 13 |
| Fatigue | 57 | 9.8% | 9 | 15 |
| Hypertension | 41 | 7.1% | 5 | 5 |
| Blood pressure increased | 39 | 6.7% | 17 | 13 |
| Weight decreased | 39 | 6.7% | 10 | 8 |
| Weight increased | 34 | 5.9% | 7 | 7 |
| Inappropriate schedule of product administration | 28 | 4.8% | 9 | 10 |
| Malaise | 28 | 4.8% | 6 | 12 |
| Asthenia | 25 | 4.3% | 6 | 12 |
| Blood pressure fluctuation | 25 | 4.3% | 10 | 9 |
| Nausea | 23 | 4.0% | 5 | 5 |
| Product dose omission issue | 23 | 4.0% | 9 | 9 |
| Dyspnoea | 22 | 3.8% | 4 | 8 |
| Platelet count decreased | 22 | 3.8% | 7 | 10 |
| Blood pressure systolic increased | 21 | 3.6% | 6 | 7 |
| Pain | 20 | 3.5% | 3 | 8 |
| Fall | 19 | 3.3% | 6 | 10 |
| Somnolence | 19 | 3.3% | 4 | 5 |
Who Reports BEVACIZUMAB-BVZR Side Effects? Age & Gender Data
Gender: 44.1% female, 55.9% male. Average age: 57.0 years. Most reports from: CA. View detailed demographics →
Is BEVACIZUMAB-BVZR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 3 | 0 | 0 |
| 2020 | 48 | 18 | 22 |
| 2021 | 50 | 16 | 17 |
| 2022 | 80 | 34 | 23 |
| 2023 | 105 | 45 | 30 |
| 2024 | 44 | 11 | 13 |
| 2025 | 10 | 1 | 2 |
What Is BEVACIZUMAB-BVZR Used For?
| Indication | Reports |
|---|---|
| Glioblastoma | 69 |
| Hepatocellular carcinoma | 30 |
| Colon cancer | 29 |
| Ovarian cancer | 23 |
| Colorectal cancer metastatic | 21 |
| Product used for unknown indication | 11 |
| Adenocarcinoma of colon | 10 |
| Rectal adenocarcinoma | 9 |
| Breast cancer metastatic | 8 |
| Colon cancer metastatic | 8 |
BEVACIZUMAB-BVZR vs Alternatives: Which Is Safer?
BEVACIZUMAB-BVZR vs BEVACIZUMAB-MALY
BEVACIZUMAB-BVZR vs BEXAROTENE
BEVACIZUMAB-BVZR vs BEZAFIBRATE
BEVACIZUMAB-BVZR vs BEZLOTOXUMAB
BEVACIZUMAB-BVZR vs BGB-11417
BEVACIZUMAB-BVZR vs BICALUTAMIDE
BEVACIZUMAB-BVZR vs BICTEGRAVIR
BEVACIZUMAB-BVZR vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BEVACIZUMAB-BVZR vs BIFIDOBACTERIUM LONGUM
BEVACIZUMAB-BVZR vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
Official FDA Label for BEVACIZUMAB-BVZR
Official prescribing information from the FDA-approved drug label.